Stock Analysis on Net
Stock Analysis on Net

Medtronic PLC (NYSE:MDT)

$24.99

Adjusted Financial Ratios

Microsoft Excel

Paying user area

The data is hidden behind: . Unhide it.

This is a one-time payment. There is no automatic renewal.


We accept:

Visa Mastercard Maestro Discover JCB PayPal Google Pay
Visa Secure Mastercard Identity Check

Adjusted Financial Ratios (Summary)

Medtronic PLC, adjusted financial ratios

Microsoft Excel
Apr 24, 2026 Apr 25, 2025 Apr 26, 2024 Apr 28, 2023 Apr 29, 2022 Apr 30, 2021
Activity Ratio
Total Asset Turnover
Reported
Adjusted
Liquidity Ratio
Current Ratio
Reported
Adjusted
Solvency Ratios
Debt to Equity
Reported
Adjusted
Debt to Capital
Reported
Adjusted
Financial Leverage
Reported
Adjusted
Profitability Ratios
Net Profit Margin
Reported
Adjusted
Return on Equity (ROE)
Reported
Adjusted
Return on Assets (ROA)
Reported
Adjusted

Based on: 10-K (reporting date: 2026-04-24), 10-K (reporting date: 2025-04-25), 10-K (reporting date: 2024-04-26), 10-K (reporting date: 2023-04-28), 10-K (reporting date: 2022-04-29), 10-K (reporting date: 2021-04-30).


The financial ratios indicate a period of consistent improvement in operational efficiency, though profitability and liquidity have experienced notable volatility over the six-year period.

Operational Efficiency
A steady upward trend is observed in asset utilization. Reported total asset turnover increased from 0.32 in 2021 to 0.39 in 2026. This trend is mirrored in the adjusted total asset turnover, which grew from 0.33 to 0.41, indicating a sustained improvement in the efficiency of generating revenue from the total asset base.
Liquidity and Solvency
Liquidity remains sufficient but exhibits fluctuation. The reported current ratio declined from a peak of 2.65 in 2021 to a low of 1.85 in 2025, before recovering to 2.13 in 2026. Regarding solvency, debt to equity and debt to capital ratios remained relatively stable until 2025, where reported debt to equity peaked at 0.59 and debt to capital reached 0.37. Financial leverage followed a similar trajectory, rising from 1.81 in 2021 to 1.91 in 2025, followed by a slight reduction to 1.88 in 2026.
Profitability and Returns
Profitability metrics demonstrate significant variance. Reported net profit margin peaked at 15.90% in 2022 before contracting to 11.36% in 2024 and recovering to 13.20% by 2026. Adjusted net profit margins showed greater volatility, with a sharp decline to 7.58% in 2023 followed by a recovery to 14.05% in 2026. Return on Equity (ROE) and Return on Assets (ROA) follow these patterns; adjusted ROE fell to 4.76% in 2023 but rebounded to 10.76% by 2026, while adjusted ROA moved from a low of 2.70% in 2023 to 5.72% in 2026.

Overall, the financial profile is characterized by improving asset efficiency and a recovery in profitability following a downturn in 2023. While leverage increased slightly toward the end of the period, liquidity levels have remained well above the critical threshold of 1.0.


Medtronic PLC, Financial Ratios: Reported vs. Adjusted



Adjusted Total Asset Turnover

Microsoft Excel
Apr 24, 2026 Apr 25, 2025 Apr 26, 2024 Apr 28, 2023 Apr 29, 2022 Apr 30, 2021
Reported
Selected Financial Data (US$ in millions)
Net sales
Total assets
Activity Ratio
Total asset turnover1
Adjusted
Selected Financial Data (US$ in millions)
Adjusted net sales2
Adjusted total assets3
Activity Ratio
Adjusted total asset turnover4

Based on: 10-K (reporting date: 2026-04-24), 10-K (reporting date: 2025-04-25), 10-K (reporting date: 2024-04-26), 10-K (reporting date: 2023-04-28), 10-K (reporting date: 2022-04-29), 10-K (reporting date: 2021-04-30).

1 2026 Calculation
Total asset turnover = Net sales ÷ Total assets
= ÷ =

2 Adjusted net sales. See details »

3 Adjusted total assets. See details »

4 2026 Calculation
Adjusted total asset turnover = Adjusted net sales ÷ Adjusted total assets
= ÷ =


An analysis of asset utilization efficiency reveals a consistent upward trend in the adjusted total asset turnover ratio over the six-year period ending April 24, 2026. This progression indicates an increasing ability to generate revenue from the company's adjusted asset base, reflecting improved operational efficiency.

Adjusted Total Asset Turnover Trend
The adjusted total asset turnover ratio demonstrates steady growth, rising from 0.33 in 2021 to 0.41 in 2026. Aside from a period of stability between 2022 and 2023 where the ratio remained at 0.36, the metric increased annually, culminating in its highest value in the final year of the period.
Revenue and Asset Dynamics
The improvement in turnover is driven by a combination of increasing adjusted net sales and a controlled asset base. Adjusted net sales grew from 30,182 million US$ in 2021 to 36,418 million US$ in 2026. Concurrently, adjusted total assets experienced a decline from 90,210 million US$ in 2021 to a low of 86,593 million US$ in 2024, before moderating back to 89,481 million US$ by 2026. The reduction in assets during the mid-period, paired with rising sales, accelerated the growth of the turnover ratio.
Comparison of Reported and Adjusted Metrics
A consistent variance is observed between reported and adjusted figures. The adjusted total asset turnover remains higher than the reported total asset turnover throughout the entire period. For instance, by April 24, 2026, the adjusted ratio reached 0.41 compared to the reported ratio of 0.39. This indicates that the adjustments applied to net sales and total assets result in a more favorable representation of asset productivity.


Adjusted Current Ratio

Microsoft Excel
Apr 24, 2026 Apr 25, 2025 Apr 26, 2024 Apr 28, 2023 Apr 29, 2022 Apr 30, 2021
Reported
Selected Financial Data (US$ in millions)
Current assets
Current liabilities
Liquidity Ratio
Current ratio1
Adjusted
Selected Financial Data (US$ in millions)
Adjusted current assets2
Adjusted current liabilities3
Liquidity Ratio
Adjusted current ratio4

Based on: 10-K (reporting date: 2026-04-24), 10-K (reporting date: 2025-04-25), 10-K (reporting date: 2024-04-26), 10-K (reporting date: 2023-04-28), 10-K (reporting date: 2022-04-29), 10-K (reporting date: 2021-04-30).

1 2026 Calculation
Current ratio = Current assets ÷ Current liabilities
= ÷ =

2 Adjusted current assets. See details »

3 Adjusted current liabilities. See details »

4 2026 Calculation
Adjusted current ratio = Adjusted current assets ÷ Adjusted current liabilities
= ÷ =


The liquidity profile exhibits a fluctuating but stable trend, with the adjusted current ratio consistently remaining well above the 1.0 threshold. This indicates a sustained capacity to meet short-term obligations through current assets, although the margin of safety varies across the analyzed period.

Adjusted Current Ratio Volatility
A cyclical pattern is observed in the adjusted current ratio, which started at 2.77 in April 2021 and experienced a contraction to 1.93 by April 2022. A recovery to 2.50 followed in April 2023, succeeded by a downward trend to 2.12 in April 2024 and a low of 1.92 in April 2025, before increasing to 2.22 in April 2026.
Comparison of Reported and Adjusted Metrics
A consistent positive variance is present between the reported current ratio and the adjusted current ratio. In every period, the adjusted ratio presents a stronger liquidity position than the reported figure. For example, by April 2026, the adjusted ratio of 2.22 exceeds the reported ratio of 2.13, indicating that the adjustments applied to current assets and liabilities systematically improve the perceived short-term solvency.
Analysis of Asset and Liability Drivers
The fluctuations in the liquidity ratios are primarily driven by volatility in adjusted current liabilities rather than adjusted current assets. Adjusted current assets demonstrated a gradual growth trajectory, rising from US$ 22,789 million in 2021 to US$ 24,977 million by 2026, with a temporary dip in 2023. Conversely, adjusted current liabilities showed significant volatility, peaking in April 2022 and April 2025, which directly corresponds to the periods of the lowest observed adjusted current ratios.


Adjusted Debt to Equity

Microsoft Excel
Apr 24, 2026 Apr 25, 2025 Apr 26, 2024 Apr 28, 2023 Apr 29, 2022 Apr 30, 2021
Reported
Selected Financial Data (US$ in millions)
Total debt
Shareholders’ equity
Solvency Ratio
Debt to equity1
Adjusted
Selected Financial Data (US$ in millions)
Adjusted total debt2
Adjusted total equity3
Solvency Ratio
Adjusted debt to equity4

Based on: 10-K (reporting date: 2026-04-24), 10-K (reporting date: 2025-04-25), 10-K (reporting date: 2024-04-26), 10-K (reporting date: 2023-04-28), 10-K (reporting date: 2022-04-29), 10-K (reporting date: 2021-04-30).

1 2026 Calculation
Debt to equity = Total debt ÷ Shareholders’ equity
= ÷ =

2 Adjusted total debt. See details »

3 Adjusted total equity. See details »

4 2026 Calculation
Adjusted debt to equity = Adjusted total debt ÷ Adjusted total equity
= ÷ =


The financial trajectory indicates a general increase in leverage over the observed period, characterized by rising adjusted debt levels and a corresponding decline in adjusted equity.

Adjusted Total Debt Trends
Adjusted total debt experienced an initial decrease from 27,404 million US$ in 2021 to 24,984 million US$ in 2022. Following this low, a sustained upward trend was observed, with debt levels peaking at 29,626 million US$ in 2025 before slightly receding to 29,148 million US$ in 2026.
Adjusted Total Equity Trends
Adjusted total equity exhibited a general downward trajectory for the majority of the period. From a starting point of 50,271 million US$ in 2021, equity declined to a low of 45,547 million US$ in 2025. A moderate recovery was noted in 2026, as equity increased to 47,561 million US$.
Adjusted Debt to Equity Ratio Analysis
The adjusted debt to equity ratio reflected the combined impact of increasing debt and decreasing equity. After a dip to 0.49 in 2022, the ratio rose steadily each year, reaching a peak of 0.65 in 2025. The ratio concluded the period at 0.61 in 2026, remaining higher than the levels observed between 2021 and 2024.
Comparison of Reported and Adjusted Leverage
A consistent divergence exists between reported and adjusted metrics. The adjusted debt to equity ratio remains systematically higher than the reported ratio across all periods. This suggests that the adjustments applied to the total debt and equity figures result in a more conservative representation of the company's leverage position.


Adjusted Debt to Capital

Microsoft Excel
Apr 24, 2026 Apr 25, 2025 Apr 26, 2024 Apr 28, 2023 Apr 29, 2022 Apr 30, 2021
Reported
Selected Financial Data (US$ in millions)
Total debt
Total capital
Solvency Ratio
Debt to capital1
Adjusted
Selected Financial Data (US$ in millions)
Adjusted total debt2
Adjusted total capital3
Solvency Ratio
Adjusted debt to capital4

Based on: 10-K (reporting date: 2026-04-24), 10-K (reporting date: 2025-04-25), 10-K (reporting date: 2024-04-26), 10-K (reporting date: 2023-04-28), 10-K (reporting date: 2022-04-29), 10-K (reporting date: 2021-04-30).

1 2026 Calculation
Debt to capital = Total debt ÷ Total capital
= ÷ =

2 Adjusted total debt. See details »

3 Adjusted total capital. See details »

4 2026 Calculation
Adjusted debt to capital = Adjusted total debt ÷ Adjusted total capital
= ÷ =


The financial trajectory from April 2021 to April 2026 reveals a gradual expansion of the leverage profile, characterized by an overall increase in the adjusted debt to capital ratio from 0.35 to 0.38.

Adjusted Debt Obligations
Adjusted total debt experienced an initial decline from US$ 27,404 million in 2021 to US$ 24,984 million in 2022. Following this dip, a sustained upward trend is observed, with debt levels climbing to a peak of US$ 29,626 million in 2025 before slightly receding to US$ 29,148 million in 2026.
Adjusted Capital Base
The adjusted total capital base exhibited a contraction over the first four years, decreasing from US$ 77,675 million in 2021 to a low of US$ 74,194 million in 2024. A reversal of this trend occurred in the final two years, with capital increasing to US$ 76,709 million by April 2026.
Leverage Ratio Trends
The adjusted debt to capital ratio remained relatively stable between 0.33 and 0.35 from 2022 through 2024. A notable increase occurred in 2025, with the ratio reaching a period high of 0.39. This spike is the result of the simultaneous increase in total debt and a slower rate of growth in the capital base. Additionally, the adjusted ratio consistently exceeds the reported debt to capital ratio in every period, suggesting that the adjustments applied to debt and capital figures result in a higher perceived leverage level than the reported figures.


Adjusted Financial Leverage

Microsoft Excel
Apr 24, 2026 Apr 25, 2025 Apr 26, 2024 Apr 28, 2023 Apr 29, 2022 Apr 30, 2021
Reported
Selected Financial Data (US$ in millions)
Total assets
Shareholders’ equity
Solvency Ratio
Financial leverage1
Adjusted
Selected Financial Data (US$ in millions)
Adjusted total assets2
Adjusted total equity3
Solvency Ratio
Adjusted financial leverage4

Based on: 10-K (reporting date: 2026-04-24), 10-K (reporting date: 2025-04-25), 10-K (reporting date: 2024-04-26), 10-K (reporting date: 2023-04-28), 10-K (reporting date: 2022-04-29), 10-K (reporting date: 2021-04-30).

1 2026 Calculation
Financial leverage = Total assets ÷ Shareholders’ equity
= ÷ =

2 Adjusted total assets. See details »

3 Adjusted total equity. See details »

4 2026 Calculation
Adjusted financial leverage = Adjusted total assets ÷ Adjusted total equity
= ÷ =


The financial structure exhibits a period of stability followed by a moderate increase in leverage peaking in 2025, with a slight correction occurring by April 2026. The overall trend indicates a managed approach to capital structure, though there is a noticeable contraction in the equity base during the mid-period.

Asset Dynamics
Adjusted total assets remained relatively stable, fluctuating within a narrow range. A gradual decline was observed from US$ 90,210 million in 2021 to a low of US$ 86,593 million in 2024, followed by a recovery to US$ 89,481 million by April 2026. This suggests a consistent scale of operations with minor adjustments in asset valuation or composition.
Equity Trends
Adjusted total equity showed a downward trajectory for a significant portion of the analyzed period. From a high of US$ 50,271 million in 2021, equity decreased to US$ 45,547 million by April 2025. This decline in the equity cushion is the primary driver behind the increase in the financial leverage ratio during the 2022 to 2025 window.
Adjusted Financial Leverage Analysis
The adjusted financial leverage ratio experienced a slight initial dip from 1.79 in 2021 to 1.72 in 2022. Subsequently, the ratio trended upward for three consecutive years, reaching a peak of 1.93 in 2025. This increase indicates a higher reliance on debt relative to equity. By April 2026, the ratio moderated to 1.88, aligned with a corresponding recovery in adjusted total equity.
Comparative Leverage Metrics
A close correlation exists between reported financial leverage and adjusted financial leverage. The two metrics track almost identically across all six years, with the adjusted ratio typically mirroring the reported ratio within a narrow margin. This suggests that the adjustments applied to assets and equity do not significantly distort the underlying leverage profile of the organization.


Adjusted Net Profit Margin

Microsoft Excel
Apr 24, 2026 Apr 25, 2025 Apr 26, 2024 Apr 28, 2023 Apr 29, 2022 Apr 30, 2021
Reported
Selected Financial Data (US$ in millions)
Net income attributable to Medtronic
Net sales
Profitability Ratio
Net profit margin1
Adjusted
Selected Financial Data (US$ in millions)
Adjusted net income2
Adjusted net sales3
Profitability Ratio
Adjusted net profit margin4

Based on: 10-K (reporting date: 2026-04-24), 10-K (reporting date: 2025-04-25), 10-K (reporting date: 2024-04-26), 10-K (reporting date: 2023-04-28), 10-K (reporting date: 2022-04-29), 10-K (reporting date: 2021-04-30).

1 2026 Calculation
Net profit margin = 100 × Net income attributable to Medtronic ÷ Net sales
= 100 × ÷ =

2 Adjusted net income. See details »

3 Adjusted net sales. See details »

4 2026 Calculation
Adjusted net profit margin = 100 × Adjusted net income ÷ Adjusted net sales
= 100 × ÷ =


The adjusted net profit margin exhibits significant volatility over the six-year period, characterized by a sharp peak in 2022, a substantial contraction in 2023, and a subsequent recovery through 2026. While adjusted net sales demonstrate a consistent upward trajectory, the efficiency of converting these sales into adjusted net income has fluctuated considerably.

Adjusted Net Profit Margin Trends
The adjusted net profit margin reached a period high of 17.79% in April 2022, followed by a precipitous decline to 7.58% in April 2023. This represents the lowest point of profitability within the analyzed timeframe. A recovery phase began in April 2024, with the margin stabilizing near 10% for two years before climbing to 14.05% by April 2026.
Revenue and Income Correlation
Adjusted net sales grew steadily from US$ 30,182 million in 2021 to US$ 36,418 million in 2026. However, adjusted net income did not mirror this linear growth, dropping from US$ 5,642 million in 2022 to US$ 2,369 million in 2023. The resurgence of adjusted net income to US$ 5,117 million by 2026 indicates a return to higher operational efficiency and a stronger alignment between revenue growth and profit realization.
Divergence Between Reported and Adjusted Margins
Significant variances are observed between reported and adjusted profit margins. In April 2022, the adjusted margin exceeded the reported margin by 1.89 percentage points. Conversely, in April 2023, a notable divergence occurred where the reported net profit margin of 12.03% was significantly higher than the adjusted margin of 7.58%, suggesting that specific adjustments in that fiscal year had a negative impact on the normalized profit figure.


Adjusted Return on Equity (ROE)

Microsoft Excel
Apr 24, 2026 Apr 25, 2025 Apr 26, 2024 Apr 28, 2023 Apr 29, 2022 Apr 30, 2021
Reported
Selected Financial Data (US$ in millions)
Net income attributable to Medtronic
Shareholders’ equity
Profitability Ratio
ROE1
Adjusted
Selected Financial Data (US$ in millions)
Adjusted net income2
Adjusted total equity3
Profitability Ratio
Adjusted ROE4

Based on: 10-K (reporting date: 2026-04-24), 10-K (reporting date: 2025-04-25), 10-K (reporting date: 2024-04-26), 10-K (reporting date: 2023-04-28), 10-K (reporting date: 2022-04-29), 10-K (reporting date: 2021-04-30).

1 2026 Calculation
ROE = 100 × Net income attributable to Medtronic ÷ Shareholders’ equity
= 100 × ÷ =

2 Adjusted net income. See details »

3 Adjusted total equity. See details »

4 2026 Calculation
Adjusted ROE = 100 × Adjusted net income ÷ Adjusted total equity
= 100 × ÷ =


The adjusted return on equity (ROE) exhibits significant volatility over the analyzed period, characterized by sharp fluctuations driven primarily by variances in adjusted net income rather than stability in the equity base. While reported ROE maintains a more consistent trajectory, the adjusted ROE demonstrates more extreme peaks and troughs, indicating that one-time or non-recurring items have a substantial impact on the underlying profitability metrics.

Adjusted ROE Trend Analysis
A highly non-linear trend is observed in the adjusted ROE, which rose from 6.75% in 2021 to a peak of 11.06% in 2022. This was followed by a sharp contraction to 4.76% in 2023, marking the lowest point in the period. A steady recovery followed, with the ratio climbing to 6.89% in 2024, 7.50% in 2025, and eventually returning to a high of 10.76% by 2026.
Net Income Influence
The volatility in the adjusted ROE is directly correlated with fluctuations in adjusted net income. The spike in 2022 was driven by adjusted net income reaching 5,642 million USD, while the 2023 decline coincided with a drop in adjusted net income to 2,369 million USD. The recovery toward 2026 is supported by a significant increase in adjusted net income, which reached 5,117 million USD.
Equity Base Dynamics
Adjusted total equity showed a general downward trend for most of the period, decreasing from 51,009 million USD in 2022 to a low of 45,547 million USD in 2025. This reduction in the equity denominator likely amplified the recovery of the adjusted ROE in the later years, as the same or higher levels of net income were generated against a smaller capital base, before equity slightly rebounded to 47,561 million USD in 2026.
Comparison of Reported vs. Adjusted ROE
The gap between reported and adjusted ROE is most pronounced in 2022 and 2023. In 2022, the adjusted ROE (11.06%) significantly outperformed the reported ROE (9.59%), whereas in 2023, the adjusted ROE (4.76%) fell well below the reported figure (7.30%), suggesting significant non-operating adjustments during those specific fiscal years.


Adjusted Return on Assets (ROA)

Microsoft Excel
Apr 24, 2026 Apr 25, 2025 Apr 26, 2024 Apr 28, 2023 Apr 29, 2022 Apr 30, 2021
Reported
Selected Financial Data (US$ in millions)
Net income attributable to Medtronic
Total assets
Profitability Ratio
ROA1
Adjusted
Selected Financial Data (US$ in millions)
Adjusted net income2
Adjusted total assets3
Profitability Ratio
Adjusted ROA4

Based on: 10-K (reporting date: 2026-04-24), 10-K (reporting date: 2025-04-25), 10-K (reporting date: 2024-04-26), 10-K (reporting date: 2023-04-28), 10-K (reporting date: 2022-04-29), 10-K (reporting date: 2021-04-30).

1 2026 Calculation
ROA = 100 × Net income attributable to Medtronic ÷ Total assets
= 100 × ÷ =

2 Adjusted net income. See details »

3 Adjusted total assets. See details »

4 2026 Calculation
Adjusted ROA = 100 × Adjusted net income ÷ Adjusted total assets
= 100 × ÷ =


The financial analysis reveals a period of volatility in operational efficiency, specifically regarding the adjusted return on assets (ROA). While the asset base remained relatively stable over the observed six-year period, profitability metrics exhibited significant variance, leading to fluctuating returns on those assets.

Adjusted ROA Volatility and Trends
The Adjusted ROA demonstrated substantial fluctuations, peaking at 6.42% in April 2022 before experiencing a sharp decline to 2.70% in April 2023. This contraction coincided with a significant drop in adjusted net income, which fell to 2,369 million US dollars. Following this low point, a steady recovery trend is observed, with the ratio increasing to 3.83% in 2024, 3.88% in 2025, and reaching 5.72% by April 2026.
Comparative Analysis of Reported vs. Adjusted Performance
A notable divergence exists between reported and adjusted ROA. In April 2022, the adjusted ROA outperformed the reported ROA (6.42% versus 5.54%), suggesting that excluded items negatively impacted the reported figure. Conversely, in April 2023, the adjusted ROA fell significantly below the reported ROA (2.70% versus 4.13%), indicating that adjustments reduced the net income figure more aggressively than the reported totals during that cycle.
Asset Base Stability
Both total assets and adjusted total assets remained remarkably consistent throughout the period. Reported assets fluctuated within a narrow range between 89,981 million and 93,083 million US dollars, while adjusted assets remained between 86,593 million and 90,210 million US dollars. Because the denominator remained stable, the volatility in the ROA is attributable almost entirely to changes in net income rather than shifts in the company's asset structure.